Immunocore Holdings PLCNASDAQ:IMCR
- LAST PRICE59.3200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots47.5500/ 1
- Ask / Lots63.0000/ 5
- Open / Previous Close58.9700 / 59.3200
- Day Range
- 52 Week Range
- Volume359,708
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IMCR |
|---|---|---|
| 09:32 ET | 3166 | 58.99 |
| 09:33 ET | 909 | 59.91 |
| 09:35 ET | 3037 | 59.75 |
| 09:37 ET | 1981 | 59.915 |
| 09:39 ET | 526 | 59.855 |
| 09:42 ET | 700 | 59.785 |
| 09:44 ET | 2181 | 59.21 |
| 09:46 ET | 900 | 59.21 |
| 09:48 ET | 1050 | 59.45 |
| 09:50 ET | 1208 | 59.605 |
| 09:51 ET | 1200 | 59.61 |
| 09:53 ET | 300 | 59.6 |
| 09:55 ET | 1100 | 59.05 |
| 09:57 ET | 100 | 59.295 |
| 10:00 ET | 700 | 59.31 |
| 10:04 ET | 1100 | 59.05 |
| 10:06 ET | 150 | 58.75 |
| 10:08 ET | 500 | 59.26 |
| 10:09 ET | 600 | 59.38 |
| 10:11 ET | 990 | 59.01 |
| 10:13 ET | 200 | 59.49 |
| 10:15 ET | 100 | 59.01 |
| 10:18 ET | 200 | 59.15 |
| 10:20 ET | 300 | 59.07 |
| 10:22 ET | 600 | 58.74 |
| 10:24 ET | 400 | 58.94 |
| 10:26 ET | 313 | 58.51 |
| 10:27 ET | 200 | 58.435 |
| 10:29 ET | 100 | 58.485 |
| 10:40 ET | 759 | 58.22 |
| 10:42 ET | 1100 | 58.18 |
| 10:44 ET | 658 | 58.55 |
| 10:45 ET | 400 | 58.515 |
| 10:47 ET | 310 | 58.42 |
| 10:49 ET | 200 | 58.6098 |
| 10:51 ET | 700 | 58.64 |
| 10:56 ET | 200 | 58.89 |
| 10:58 ET | 315 | 58.695 |
| 11:00 ET | 842 | 59.09 |
| 11:02 ET | 500 | 59.35 |
| 11:03 ET | 100 | 59.355 |
| 11:05 ET | 200 | 59.295 |
| 11:07 ET | 436 | 59.46 |
| 11:09 ET | 200 | 59.46 |
| 11:12 ET | 400 | 59.35 |
| 11:14 ET | 900 | 59.16 |
| 11:20 ET | 711 | 58.905 |
| 11:21 ET | 150 | 58.52 |
| 11:25 ET | 1045 | 58.49 |
| 11:27 ET | 686 | 58.35 |
| 11:32 ET | 100 | 58.195 |
| 11:34 ET | 383 | 58.41 |
| 11:38 ET | 1200 | 58.2 |
| 11:39 ET | 702 | 58.5 |
| 11:41 ET | 700 | 58.62 |
| 11:43 ET | 473 | 58.76 |
| 11:48 ET | 100 | 58.57 |
| 11:54 ET | 100 | 58.49 |
| 12:06 ET | 700 | 58.27 |
| 12:08 ET | 200 | 58.155 |
| 12:14 ET | 100 | 58.02 |
| 12:15 ET | 200 | 58.125 |
| 12:17 ET | 912 | 57.97 |
| 12:19 ET | 900 | 58.28 |
| 12:24 ET | 2100 | 58.28 |
| 12:30 ET | 800 | 58.415 |
| 12:37 ET | 400 | 58.3 |
| 12:42 ET | 200 | 58.61 |
| 12:44 ET | 100 | 58.65 |
| 12:46 ET | 100 | 58.62 |
| 12:48 ET | 200 | 58.61 |
| 12:50 ET | 500 | 58.62 |
| 12:55 ET | 600 | 58.69 |
| 01:02 ET | 800 | 58.68 |
| 01:04 ET | 561 | 58.81 |
| 01:06 ET | 100 | 58.86 |
| 01:11 ET | 935 | 58.945 |
| 01:13 ET | 600 | 59.1 |
| 01:18 ET | 1100 | 59.065 |
| 01:22 ET | 900 | 58.93 |
| 01:27 ET | 100 | 58.89 |
| 01:29 ET | 295 | 58.85 |
| 01:31 ET | 232 | 59 |
| 01:36 ET | 600 | 59.01 |
| 01:38 ET | 200 | 58.91 |
| 01:40 ET | 2500 | 59.075 |
| 01:42 ET | 100 | 59.24 |
| 01:44 ET | 200 | 59.205 |
| 01:45 ET | 600 | 59.385 |
| 01:47 ET | 1000 | 59.51 |
| 01:49 ET | 1790 | 59.08 |
| 01:51 ET | 100 | 59.08 |
| 01:56 ET | 100 | 59.18 |
| 01:58 ET | 1500 | 59.26 |
| 02:00 ET | 200 | 59.28 |
| 02:02 ET | 1600 | 59.15 |
| 02:05 ET | 800 | 59.085 |
| 02:09 ET | 1417 | 59.355 |
| 02:12 ET | 200 | 59.285 |
| 02:14 ET | 300 | 59.36 |
| 02:16 ET | 200 | 59.295 |
| 02:18 ET | 2707 | 59.39 |
| 02:20 ET | 1300 | 59.12 |
| 02:21 ET | 300 | 59.18 |
| 02:23 ET | 670 | 59.12 |
| 02:25 ET | 1358 | 59.18 |
| 02:27 ET | 409 | 59.36 |
| 02:30 ET | 100 | 59.13 |
| 02:32 ET | 2100 | 59.05 |
| 02:36 ET | 300 | 58.93 |
| 02:38 ET | 327 | 59.12 |
| 02:39 ET | 300 | 59.04 |
| 02:41 ET | 300 | 59.04 |
| 02:43 ET | 908 | 59.18 |
| 02:45 ET | 100 | 59.29 |
| 02:50 ET | 1000 | 59.36 |
| 02:52 ET | 300 | 59.28 |
| 02:54 ET | 600 | 59.35 |
| 02:56 ET | 1700 | 59.025 |
| 02:57 ET | 1920 | 58.855 |
| 02:59 ET | 402 | 58.89 |
| 03:01 ET | 100 | 58.95 |
| 03:03 ET | 2635 | 59.12 |
| 03:06 ET | 400 | 59.005 |
| 03:08 ET | 500 | 58.975 |
| 03:10 ET | 300 | 58.865 |
| 03:14 ET | 1153 | 58.59 |
| 03:15 ET | 100 | 58.54 |
| 03:17 ET | 1217 | 58.59 |
| 03:19 ET | 200 | 58.59 |
| 03:21 ET | 400 | 58.48 |
| 03:24 ET | 1415 | 58.725 |
| 03:26 ET | 1500 | 58.705 |
| 03:28 ET | 1321 | 58.8 |
| 03:30 ET | 100 | 58.81 |
| 03:32 ET | 1756 | 58.87 |
| 03:33 ET | 800 | 58.97 |
| 03:35 ET | 2200 | 58.97 |
| 03:37 ET | 1234 | 58.81 |
| 03:39 ET | 15582 | 59.08 |
| 03:42 ET | 2100 | 58.97 |
| 03:44 ET | 400 | 58.97 |
| 03:46 ET | 800 | 59.075 |
| 03:48 ET | 1619 | 59.07 |
| 03:50 ET | 1652 | 59.04 |
| 03:51 ET | 67190 | 58.935 |
| 03:53 ET | 59069 | 59.01 |
| 03:55 ET | 3800 | 59.05 |
| 03:57 ET | 5588 | 59.23 |
| 04:00 ET | 19751 | 59.32 |
Dec 2, 2022
Immunocore Working With Gadeta to Develop Therapy for Solid Tumors, from 8:19AM ET on Friday Dec 02, 2022 by MT Newswires
8:19AM ET on Friday Dec 02, 2022 by MT NewswiresBRIEF-Immunocore And Gadeta Announce Agreement To Develop First Gamma Delta (Γδ) Tcr Immtac For Solid Tumors, from 7:35AM ET on Friday Dec 02, 2022 by Thomson Reuters
7:35AM ET on Friday Dec 02, 2022 by Thomson ReutersImmunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors, from 7:30AM ET on Friday Dec 02, 2022 by GlobeNewswire
7:30AM ET on Friday Dec 02, 2022 by GlobeNewswire
Nov 30, 2022
--Barclays Initiates Immunocore Holdings With Overweight Rating, Sets $80 Price Target, from 8:09AM ET on Wednesday Nov 30, 2022 by MT Newswires
8:09AM ET on Wednesday Nov 30, 2022 by MT Newswires
Nov 23, 2022
Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference, from 7:00AM ET on Wednesday Nov 23, 2022 by GlobeNewswire
7:00AM ET on Wednesday Nov 23, 2022 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Immunocore Holdings PLC | 2.6B | -38.1x | --- |
Beam Therapeutics Inc | 3.1B | -9.5x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,297.4x | --- |
Axsome Therapeutics Inc | 3.4B | -18.5x | --- |
Intellia Therapeutics Inc | 3.5B | -6.6x | --- |
Vaxcyte Inc | 3.5B | -14.6x | --- |
Company Information
Immunocore Holdings plc, formerly Immunocore Holdings Ltd, is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. The Company’s pipeline is leveraging ImmTAX platform within three therapeutic areas: oncology, infectious disease and autoimmune disease. Its product candidate KIMMTRAK is used for positive adult patients with unresectable or metastatic uveal melanoma (mUM) having demonstrated in Phase III clinical trial.
Contact Information
- Headquarters
- 90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
- Phone
- 123-543-8600
- Fax
- ---
Executives
- Independent Chairman of the Board
- John Bell
- Chief Executive Officer, Director
- Bahija Jallal
- Chief Financial Officer, Head of Strategy
- Brian Di Donato
- Chief Human Resource Officer
- Tina St Leger
- Head of Research and Development
- David Berman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $124.1M |
Shares Outstanding | 45.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.56 |
Book Value | $4.75 |
P/E Ratio | -38.1x |
Price/Sales (TTM) | 21.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -53.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
